eCM 2012
DOI: 10.22203/ecm.v023a13
|View full text |Cite
|
Sign up to set email alerts
|

Multivalent structure of galectin-1-nanogold complex serves as potential therapeutics for rheumatoid arthritis by enhancing receptor clustering

Abstract: Cellular behaviour is controlled by numerous processes, including intracellular signalling pathways that are triggered by the binding of ligands with cell surface receptors. Multivalent ligands have multiple copies of a recognition element that binds to receptors and infl uences downstream signals. Nanoparticle-ligand complexes may form multivalent structures to crosslink receptors with high avidity and specifi city. After conjugation of galectin-1 onto gold nanoparticles, the resulting nanogold-galectin-1 (Au… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
26
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 44 publications
(26 citation statements)
references
References 32 publications
0
26
0
Order By: Relevance
“…GNP were recently proposed as a new treatment for arthritis and other rheumatic diseases due to their anti‐inflammatory properties . Pereira et al.…”
Section: Gold Nanoparticles For Ophthalmic Therapymentioning
confidence: 99%
“…GNP were recently proposed as a new treatment for arthritis and other rheumatic diseases due to their anti‐inflammatory properties . Pereira et al.…”
Section: Gold Nanoparticles For Ophthalmic Therapymentioning
confidence: 99%
“…Cell receptors : potentially any non- or slowly internalizing cell surface antigen can be a target, such as CD45 (T-cell, B-cell, macrophage), 157 death receptor 4 (breast and colon cancers, etc. ), 158 prostate stem cell antigen (prostate cancer), 159 and carcinoembryonic antigen (many tumor types, but not on normal cells).…”
Section: Conclusion and Beyondmentioning
confidence: 99%
“…Galectin-1, for example, is a multivalent carbohydrate binding protein that mediates the malignant cellular activities by cross-linking glycoproteins in the tumor microenvironment. Specifically, galectin-1 has been reported to be involved in multivalent mechanisms that cluster cell surface glycoproteins [ 8 , 9 ], cross-link receptors [ 10 , 11 ], and form lattices and larger aggregates [ 12 , 13 , 14 ].…”
Section: Introductionmentioning
confidence: 99%